Results 1 to 10 of about 12,661 (240)
Some of the next articles are maybe not open access.
Ctla4 and multiple sclerosis in the Italian population
Experimental and Molecular Pathology, 2005CTLA4 protein is a receptor molecule that plays a critical role as a negative regulator of the immune response. Therefore, genetic variations in CTLA4 may confer susceptibility to autoimmune diseases such as multiple sclerosis (MS). In order to investigate the association of two CTLA4 polymorphisms (+49 A/G and -318 C/T) with multiple sclerosis ...
G Malferrari +7 more
openaire +2 more sources
A recombinant influenza virus with a CTLA4‐specific scFv inhibits tumor growth in a mouse model
Cell Biology International, 2021Oncolytic viruses (OV) have shown excellent safety and efficacy in preclinical and clinical studies. Influenza A virus (IAV) is considered a promising oncolytic virus.
Guang-Lin Lei +9 more
semanticscholar +1 more source
Interactions of CD80 and CD86 with CD28 and CTLA4
The Journal of Immunology, 1996Abstract CD80 and CD86 are cell surface glycoproteins expressed on a variety of professional APCs. They have attracted much attention due to their function as potent costimulators of T lymphocyte function through their interaction with CD28 and possibly CTLA4. Because inhibitors of this interaction may have therapeutic relevance in human
J H, Ellis +4 more
openaire +2 more sources
CTLA4 dimorphisms and the multiple sclerosis phenotype
Journal of Neuroimmunology, 2002Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), expressed on activated T cells, binds to B7 molecules on antigen-presenting cells. Signaling via CTLA-4 results in downregulation of ongoing T-cell clonal expansion. A single-nucleotide polymorphism (SNP) in exon 1 of CTLA4 is associated with susceptibility to several autoimmune diseases, including ...
Thomas, Masterman +6 more
openaire +2 more sources
Protection of Corneal Allografts by CTLA4-Ig
Cornea, 1999CTLA4, a high-affinity ligand of B7, can, in soluble form, prevent antigen-driven T-cell activation by blocking CD28-B7 interaction and can thereby prevent immune graft rejection. In this study, we tested the capacity of soluble CTLA4-Ig alone or in combination with UV-B irradiation to suppress corneal allograft rejection in rabbits.Corneas from Dutch ...
B M, Gebhardt +3 more
openaire +2 more sources
CTLA4 is associated with susceptibility to multiple sclerosis
Journal of Neuroimmunology, 2003We comprehensively screened CTLA4 for novel genetic variations in patients with MS. We studied genetic variations by association methods in a population-based sample of 122 sporadic patients with MS and 244 age-, gender- and ethnicity-matched controls, and by linkage and family-based association methods in 395 individuals from 59 American multiplex ...
Orhun H, Kantarci +9 more
openaire +2 more sources
Turning up the heat: CTLA4 blockade in urothelial cancer
Nature reviews. Urology, 2023C. Stockem +2 more
semanticscholar +1 more source
IMMUNOMODULATION WITH CTLA4-Ig IN ISLET TRANSPLANTATION
Transplantation, 2002The need for permanent, nonspecific, and potentially harmful immunosuppression remains a major obstacle for islet transplantation. The response of a type 1 diabetic recipient to an islet graft includes a specific allogenic immune response and the recurrence of autoimmunity.
openaire +2 more sources
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Nature, 2003H. Ueda +52 more
semanticscholar +1 more source
CTLA4 polymorphisms and Graves’ disease
Cellular Immunology, 2020Beuy, Joob, Viroj, Wiwanitkit
openaire +2 more sources

